BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15231048)

  • 21. High performance liquid chromatographic analysis of St. John's wort with photodiode array detection.
    Li W; Fitzloff JF
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):99-105. PubMed ID: 11817315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. St John's wort (Hypericum perforatum) in major depression.
    Shelton RC
    J Clin Psychiatry; 2009; 70 Suppl 5():23-7. PubMed ID: 19909690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells.
    Kientsch U; Bürgi S; Ruedeberg C; Probst S; Honegger UE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S56-60. PubMed ID: 11518078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis and stability of the constituents of artichoke and St. John's wort tinctures by HPLC-DAD and HPLC-MS.
    Bilia AR; Bergonzi MC; Mazzi G; Vincieri FF
    Drug Dev Ind Pharm; 2002 May; 28(5):609-19. PubMed ID: 12098850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.
    Rahman SZ; Basilakis J; Rahmadi A; Lujic S; Musgrave I; Jorm L; Hay P; Münch G
    Australas Psychiatry; 2013 Jun; 21(3):262-6. PubMed ID: 23439542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells.
    Abegg VF; Panajatovic MV; Mancuso RV; Allard JA; Duthaler U; Odermatt A; Krähenbühl S; Bouitbir J
    Toxicol Lett; 2024 Mar; 393():1-13. PubMed ID: 38219807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of action of St. Johns wort extract].
    Müller WE; Singer A; Wonnemann M
    Praxis (Bern 1994); 2000 Dec; 89(50):2111-21. PubMed ID: 11155494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
    Schwarz D; Kisselev P; Roots I
    Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
    Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
    Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. St. John's wort: a new alternative for depression?
    Josey ES; Tackett RL
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):111-9. PubMed ID: 10190758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
    Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
    Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.